From Dean Crowe Vincristine is the most commonly used childhood cancer chemotherapy drug, and it works by stopping the cancer cells from separating into two new cells. Its job is to stop the cancer from growing. And now, because of the shortage, kids are being denied vincristine. The Vincristine Shortage: What You Need to Know On Monday, October 14, 2019 the New York Times reported that there was a shortage of vincristine. https://nyti.ms/2MBtKCM The article stated that the shortage was due to a manufacturing issue that the sole supplier of vincristine in the United States, Pfizer Pharmaceuticals, was experiencing. The FDA and Pfizer both confirmed the manufacturing issue. That same day, Rally heard from parents that their children were denied vincristine. One child was told that, even after having his port accessed so vincristine could be administered, he would not be getting the...
